Home > Insider Trading > Filing (0000899243-16-024116)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1105533	Argos Therapeutics Inc	ARGS	Pharmaceutical Preparations (2834)	562110007

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1543084	Sander Deventer Van	C/O Forbion Capital Partners Gooimeer 2-35 1411 Dc Naarden P7		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-06-29	1,322,618	$0.00	4,654,507	No	4	P	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnotes

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrants (right to buy)	Acquisiton	2016-06-29	991,964	$0.00	991,964	$5.35

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
991,964	2016-06-29	2021-06-29	No	4	P	Indirect

Footnotes

The reported securities are included within Units purchased by the Reporting Person for $5.44375 per Unit. Each Unit consists of one share of common stock and one warrant to purchase 0.75 shares of common stock.
The reported securities purchased by the Reporting Person are held of record by ForArgos B.V.
Forbion 1 Management B.V., the director of ForArgos, B.V., has voting and investment power over the reported securities held by ForArgos B.V., which are exercised through Forbion 1 Management B.V.'s investment committee, consisting of H. A. Slootweg, M. A. van Osch, G. J. Mulder and the Reporting Person. None of the members of the investment committee have individual voting and investment power with respect to such securities, and the members disclaim beneficial ownership of such securities except to the extent of their proportionate pecuniary interests therein.